Amdocs (DOX) Competitors $61.89 +0.12 (+0.19%) As of 10:56 AM Eastern This is a fair market value price provided by Massive. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsInsider TradesNews and TrendsOptions ChainOwnershipSEC FilingsShort Interest DOX vs. CTSH, EXLS, SSNC, ACN, and GIBShould you buy Amdocs stock or one of its competitors? Amdocs's main competitors and comparable companies include Cognizant Technology Solutions (CTSH), ExlService (EXLS), SS&C Technologies (SSNC), Accenture (ACN), and CGI Group (GIB). Companies are selected based on similarities in market, industry, and size. DOX vs. CTSHDOX vs. EXLSDOX vs. SSNCDOX vs. ACNDOX vs. GIBHow does Amdocs compare to Cognizant Technology Solutions?Amdocs (NASDAQ:DOX) and Cognizant Technology Solutions (NASDAQ:CTSH) are both technology companies, but which is the superior business? We will compare the two businesses based on the strength of their profitability, institutional ownership, earnings, media sentiment, analyst recommendations, risk, dividends and valuation. Is DOX or CTSH more profitable? Company Net Margins Return on Equity Return on Assets AmdocsN/A N/A N/A Cognizant Technology Solutions N/A N/A N/A Do institutionals and insiders believe in DOX or CTSH? 92.0% of Amdocs shares are owned by institutional investors. Comparatively, 92.4% of Cognizant Technology Solutions shares are owned by institutional investors. 15.4% of Amdocs shares are owned by insiders. Comparatively, 0.4% of Cognizant Technology Solutions shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth. Which has better valuation & earnings, DOX or CTSH? Cognizant Technology Solutions is trading at a lower price-to-earnings ratio than Amdocs, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioAmdocsN/AN/AN/A$4.2014.71Cognizant Technology SolutionsN/AN/AN/A$4.6514.24 Do analysts prefer DOX or CTSH? Amdocs presently has a consensus target price of $86.67, indicating a potential upside of 40.31%. Cognizant Technology Solutions has a consensus target price of $68.04, indicating a potential upside of 2.75%. Given Amdocs' higher probable upside, research analysts plainly believe Amdocs is more favorable than Cognizant Technology Solutions.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Amdocs 1 Sell rating(s) 3 Hold rating(s) 3 Buy rating(s) 0 Strong Buy rating(s) 2.29Cognizant Technology Solutions 0 Sell rating(s) 14 Hold rating(s) 10 Buy rating(s) 0 Strong Buy rating(s) 2.42 Does the media refer more to DOX or CTSH? In the previous week, Cognizant Technology Solutions had 38 more articles in the media than Amdocs. MarketBeat recorded 41 mentions for Cognizant Technology Solutions and 3 mentions for Amdocs. Amdocs' average media sentiment score of 1.30 beat Cognizant Technology Solutions' score of 1.10 indicating that Amdocs is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Amdocs 2 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Cognizant Technology Solutions 21 Very Positive mention(s) 11 Positive mention(s) 4 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive SummaryCognizant Technology Solutions beats Amdocs on 5 of the 8 factors compared between the two stocks.How does Amdocs compare to ExlService?ExlService (NASDAQ:EXLS) and Amdocs (NASDAQ:DOX) are related companies, but which is the superior business? We will contrast the two businesses based on the strength of their media sentiment, institutional ownership, valuation, dividends, analyst recommendations, earnings, profitability and risk. Which has preferable valuation and earnings, EXLS or DOX? Amdocs is trading at a lower price-to-earnings ratio than ExlService, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioExlServiceN/AN/AN/A$1.5925.74AmdocsN/AN/AN/A$4.2014.71 Is EXLS or DOX more profitable? Company Net Margins Return on Equity Return on Assets ExlServiceN/A N/A N/A Amdocs N/A N/A N/A Do institutionals & insiders have more ownership in EXLS or DOX? 92.9% of ExlService shares are held by institutional investors. Comparatively, 92.0% of Amdocs shares are held by institutional investors. 3.7% of ExlService shares are held by company insiders. Comparatively, 15.4% of Amdocs shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth. Do analysts rate EXLS or DOX? ExlService currently has a consensus target price of $44.50, indicating a potential upside of 8.72%. Amdocs has a consensus target price of $86.67, indicating a potential upside of 40.31%. Given Amdocs' higher probable upside, analysts clearly believe Amdocs is more favorable than ExlService.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score ExlService 0 Sell rating(s) 1 Hold rating(s) 6 Buy rating(s) 0 Strong Buy rating(s) 2.86Amdocs 1 Sell rating(s) 3 Hold rating(s) 3 Buy rating(s) 0 Strong Buy rating(s) 2.29 Does the media favor EXLS or DOX? In the previous week, ExlService had 11 more articles in the media than Amdocs. MarketBeat recorded 14 mentions for ExlService and 3 mentions for Amdocs. Amdocs' average media sentiment score of 1.30 beat ExlService's score of 0.82 indicating that Amdocs is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment ExlService 4 Very Positive mention(s) 1 Positive mention(s) 6 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Positive Amdocs 2 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive SummaryExlService and Amdocs tied by winning 4 of the 8 factors compared between the two stocks.How does Amdocs compare to SS&C Technologies?Amdocs (NASDAQ:DOX) and SS&C Technologies (NASDAQ:SSNC) are related companies, but which is the better business? We will contrast the two companies based on the strength of their profitability, dividends, analyst recommendations, institutional ownership, valuation, risk, earnings and media sentiment. Do analysts prefer DOX or SSNC? Amdocs presently has a consensus target price of $86.67, indicating a potential upside of 40.31%. SS&C Technologies has a consensus target price of $96.57, indicating a potential upside of 20.38%. Given Amdocs' higher probable upside, equities research analysts plainly believe Amdocs is more favorable than SS&C Technologies.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Amdocs 1 Sell rating(s) 3 Hold rating(s) 3 Buy rating(s) 0 Strong Buy rating(s) 2.29SS&C Technologies 1 Sell rating(s) 2 Hold rating(s) 8 Buy rating(s) 1 Strong Buy rating(s) 2.75 Which has better valuation and earnings, DOX or SSNC? Amdocs is trading at a lower price-to-earnings ratio than SS&C Technologies, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioAmdocsN/AN/AN/A$4.2014.71SS&C TechnologiesN/AN/AN/A$3.4823.05 Is DOX or SSNC more profitable? Company Net Margins Return on Equity Return on Assets AmdocsN/A N/A N/A SS&C Technologies N/A N/A N/A Does the media prefer DOX or SSNC? In the previous week, SS&C Technologies had 36 more articles in the media than Amdocs. MarketBeat recorded 39 mentions for SS&C Technologies and 3 mentions for Amdocs. Amdocs' average media sentiment score of 1.30 beat SS&C Technologies' score of 0.52 indicating that Amdocs is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Amdocs 2 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive SS&C Technologies 8 Very Positive mention(s) 7 Positive mention(s) 14 Neutral mention(s) 2 Negative mention(s) 1 Very Negative mention(s) Positive Do insiders and institutionals believe in DOX or SSNC? 92.0% of Amdocs shares are held by institutional investors. Comparatively, 96.9% of SS&C Technologies shares are held by institutional investors. 15.4% of Amdocs shares are held by company insiders. Comparatively, 16.0% of SS&C Technologies shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth. SummarySS&C Technologies beats Amdocs on 6 of the 9 factors compared between the two stocks.How does Amdocs compare to Accenture?Accenture (NYSE:ACN) and Amdocs (NASDAQ:DOX) are both technology companies, but which is the better stock? We will contrast the two companies based on the strength of their analyst recommendations, institutional ownership, valuation, profitability, risk, earnings, dividends and media sentiment. Which has higher earnings & valuation, ACN or DOX? Amdocs is trading at a lower price-to-earnings ratio than Accenture, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioAccentureN/AN/AN/A$13.5617.35AmdocsN/AN/AN/A$4.2014.71 Does the media prefer ACN or DOX? In the previous week, Accenture had 41 more articles in the media than Amdocs. MarketBeat recorded 44 mentions for Accenture and 3 mentions for Amdocs. Amdocs' average media sentiment score of 1.30 beat Accenture's score of 0.87 indicating that Amdocs is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Accenture 29 Very Positive mention(s) 3 Positive mention(s) 6 Neutral mention(s) 2 Negative mention(s) 1 Very Negative mention(s) Positive Amdocs 2 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Is ACN or DOX more profitable? Company Net Margins Return on Equity Return on Assets AccentureN/A N/A N/A Amdocs N/A N/A N/A Do analysts rate ACN or DOX? Accenture currently has a consensus target price of $221.07, indicating a potential downside of 6.03%. Amdocs has a consensus target price of $86.67, indicating a potential upside of 40.31%. Given Amdocs' higher possible upside, analysts plainly believe Amdocs is more favorable than Accenture.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Accenture 0 Sell rating(s) 17 Hold rating(s) 10 Buy rating(s) 0 Strong Buy rating(s) 2.37Amdocs 1 Sell rating(s) 3 Hold rating(s) 3 Buy rating(s) 0 Strong Buy rating(s) 2.29 Do institutionals & insiders have more ownership in ACN or DOX? 75.1% of Accenture shares are owned by institutional investors. Comparatively, 92.0% of Amdocs shares are owned by institutional investors. 0.0% of Accenture shares are owned by insiders. Comparatively, 15.4% of Amdocs shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term. SummaryAccenture and Amdocs tied by winning 4 of the 8 factors compared between the two stocks.How does Amdocs compare to CGI Group?Amdocs (NASDAQ:DOX) and CGI Group (NYSE:GIB) are both technology companies, but which is the superior business? We will contrast the two businesses based on the strength of their institutional ownership, profitability, analyst recommendations, media sentiment, earnings, risk, valuation and dividends. Does the media favor DOX or GIB? In the previous week, Amdocs had 1 more articles in the media than CGI Group. MarketBeat recorded 3 mentions for Amdocs and 2 mentions for CGI Group. Amdocs' average media sentiment score of 1.30 beat CGI Group's score of 0.00 indicating that Amdocs is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Amdocs 2 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive CGI Group 0 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Is DOX or GIB more profitable? Company Net Margins Return on Equity Return on Assets AmdocsN/A N/A N/A CGI Group N/A N/A N/A Do analysts prefer DOX or GIB? Amdocs presently has a consensus target price of $86.67, suggesting a potential upside of 40.31%. CGI Group has a consensus target price of $83.67, suggesting a potential upside of 4.95%. Given Amdocs' stronger consensus rating and higher probable upside, analysts plainly believe Amdocs is more favorable than CGI Group.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Amdocs 1 Sell rating(s) 3 Hold rating(s) 3 Buy rating(s) 0 Strong Buy rating(s) 2.29CGI Group 0 Sell rating(s) 7 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 2.00 Which has stronger valuation and earnings, DOX or GIB? CGI Group is trading at a lower price-to-earnings ratio than Amdocs, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioAmdocsN/AN/AN/A$4.2014.71CGI GroupN/AN/AN/A$5.8313.67 Do institutionals and insiders have more ownership in DOX or GIB? 92.0% of Amdocs shares are held by institutional investors. Comparatively, 66.7% of CGI Group shares are held by institutional investors. 15.4% of Amdocs shares are held by insiders. Comparatively, 9.9% of CGI Group shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth. SummaryAmdocs beats CGI Group on 7 of the 8 factors compared between the two stocks. Get Amdocs News Delivered to You Automatically Sign up to receive the latest news and ratings for DOX and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding DOX and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart DOX vs. The Competition ExportMetricAmdocsIT Services IndustryTechnology SectorNASDAQ ExchangeMarket Cap$6.68B$6.51B$25.61B$10.72BDividend Yield3.63%3.19%3.25%4.52%P/E Ratio14.7436.8643.3031.96Price / Sales1.443.455.205.46Price / CashN/A17.5419.5221.70Price / BookN/A3.645.073.54Net IncomeN/A$88.02M$105.96M-$27.85M7 Day Performance0.47%-0.94%0.14%-0.35%1 Month Performance7.78%-5.10%-2.89%-6.07%1 Year Performance-26.67%-2.82%5.12%-6.61% Amdocs Competitors List ExportCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)DOXAmdocs4.9006 of 5 stars$61.89+0.2%$86.67+40.0%-26.7%$6.68B$4.65B14.7426,969Positive NewsCTSHCognizant Technology Solutions3.5515 of 5 stars$65.77+5.3%$64.70-1.6%-2.7%$29.63B$21.64B14.14351,600Trending NewsUpcoming EarningsAnalyst ForecastEXLSExlService4.0331 of 5 stars$39.10+4.7%$44.50+13.8%-1.3%$5.93B$2.09B24.5965,000News CoverageEarnings ReportAnalyst UpgradeSSNCSS&C Technologies4.6511 of 5 stars$84.19+2.6%$92.63+10.0%-6.1%$19.76B$6.27B24.1928,800Earnings ReportACNAccenture4.3778 of 5 stars$224.84+4.6%$219.26-2.5%-6.3%$150.15B$74.18B16.58779,000Analyst ForecastInsider Trade Related Companies and Tools Related Companies Cognizant Technology Solutions Competitors ExlService Competitors SS&C Technologies Competitors Accenture Competitors CGI Group Competitors Wipro Competitors EPAM Systems Competitors Kyndryl Competitors DXC Technology Competitors Formula Systems (1985) Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:DOX) was last updated on 10/28/2026 by MarketBeat.com Staff. From Our PartnersFinancial legend: “This is bad, really bad...”Dr. Martin D. Weiss has publicly predicted six major American market crashes over his 55-year career, each war...Weiss Ratings | SponsoredElon Musk’s One Stock Retirement PlanStanley Druckenmiller once said you don't get rich diversifying into 50 mediocre assets - you get rich finding...Brownstone Research | Sponsored80 Days Until America's Rare Earth Supply Chain ShiftChina controls more than 90% of global rare earth alloy production, leverage it is using to restrict exports t...The Tomorrow Investor | SponsoredMy next big call (under $1)17,556% on KDA. 3,900% on PRE. 2,650% on OCEAN. Every single one of these was recommended to our community bef...Crypto 101 Media | SponsoredBezos… DOOMED?A single FCC filing hints Elon Musk is planning his biggest project yet - bigger than Tesla, SpaceX, and X com...Paradigm Press | SponsoredThe chip inside every TeslaEvery Tesla built since 2012 pays this small, overlooked supplier a fee for its technology. So does every Star...Behind the Markets | SponsoredAnd they say the headline number understates what’s really happening.Goldman Sachs just admitted it underestimated central bank gold purchases by more than 500 percent, with buyin...Cedar Gold Group | SponsoredExecutive Order 14241 Unleashes Trump’s New DollarA landmark executive order, 14241, is reportedly set to reshape how Americans use money starting this December...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Amdocs Limited Please log in to your account or sign up in order to add this asset to your watchlist. Share Amdocs With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
